Where Are the Biggest Opportunities in Women’s Cardiovascular Health?
MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as priorities for women’s cardiovascular health.
Abbott Enters TAVI Device Market Dominated by Edwards, Medtronic
Abbott recently earned FDA approval for its latest transcatheter aortic valve implantation (TAVI) system, which is named Navitor. Abbott will have to fight for its place the U.S. TAVI device space, as the systems made by Edwards and Medtronic have a steadfast command of the market share.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
Healthcare Hires of Note
Read about executive hires across healthcare and life sciences.
MedCity Pivot podcast: Reflecting on the 10-year anniversary of FDA’s approval of transcatheter aortic valve replacement
Edwards Lifesciences introduced TAVR to the U.S. back in November 2011 when FDA approved its Sapien heart valve for patients with aortic stenosis who were too sick to undergo open heart surgery. This episode of Pivot features Larry Wood, corporate vice president for TAVR with Edwards, who reflects on the journey.
Edwards makes another big acquisition in the transcatheter mitral valve space, this time for $690M
Edwards Lifesciences is paying up to $690 million to a buy an Israeli company that makes transcatheter mitral valve and tricuspid repair devices. Last year it bought a mitral valve replacement company for about $400 million.
Should J&J buy Edwards Lifesciences?
Johnson & Johnson's chief executive is on the hunt for a structural heart company to add to its medical devices business. Does it make sense to buy a company that is the big name in the market?
presented by
The AI-Native Clinician Is Already Here. Medical Education and Health Systems Need to Catch Up.
Medical students, residents, and fellows are not waiting for formal guidance on artificial intelligence before putting it to use.
Heart failure startup CardioKinetix gets $50M in round led by Edwards Lifesciences
Heart failure device startup CardioKinetix should have ample funding to wrap up a pivotal clinical trial that’ll allow it to receive pre-market approval from the FDA: It just raised $50 million in financing, led by Edwards Lifesciences Corp. – which also scooped up exclusive rights to acquire CardioKinetix based on future regulatory milestones. Menlo Park-based CardioKinetix has […]
Q & A: Collaboration between physicians and medical technology companies crucial
by Chris White and Diane Biagianti Partners for Healthy Dialogues partner Christopher White (general counsel, AdvaMed) recently sat down with Diane Biagianti, vice president, chief responsibility officer, Edwards Lifesciences, to talk about the importance of collaboration between physicians and medical technology companies, and implementing the Physician Payments Sunshine Act. How do patients benefit from interactions […]
Edwards Lifesciences jumps in mitral valve tech race with startup investment
Edwards Lifesciences (EW) joined BioMedPartners to add $3 million to Middle Peak Medical‘s already oversubscribed Series A round. The funding will go toward commercializing technology to treat mitral valve disease. Lead investors Wellington Partners and Seventure Partners, added to their investment from the first close, which also included High-Tech Gruenderfonds, according to a press release. In […]
What Starbucks, #PSL and Teavana can teach top medical device companies
As global medical device companies try to take on more of the care continuum, they might be able to turn to that little Starbucks coffee shop just around the corner. It might seem sacrilege to compare the intricacies of neuromodulation with a perfectly brewed, expertly crafted cup of joe, but here I find myself. Why? […]
How Innovation in BTK Inhibitor Development Is Improving Treatment Outcomes
BTK inhibitor has become an important treatment option for certain B-cell malignancies.
Medtronic’s busy day at the U.S. Supreme Court
The U.S. Supreme Court has decided to reject a Medtronic (MDT) appeal and leave the Edwards Lifesciences (EW) valve patent intact, which stands to lose Medtronic as much as $200 million, Bloomberg reports. The medical device company has received a big blow in its battle with Edwards Lifesciences, but the court may hear its arguments against a patient-plaintiff. The […]
EW performs slightly better than expected in Q2, looks forward to SAPIEN, mitral developments
Edwards LifeSciences Corp. reported a total revenue of $517 million for Q2, with 7.3 percent increased net sales, “driven by strong sales of transcatheter and surgical heart valves in both the U.S. and Europe,” CEO Michael Mussalem said. Combined, the two provided 16 percent of sales in the U.S., helped by the SAPIEN launch in the U.S.. […]
The cost of Medtronic’s battle with Edwards Lifesciences over TAVI: $245M, so far
Medtronic’s (NYSE:MDT) legal battle with Edwards Lifesciences over patent infringement and its transcatheter aortic valve products has been going on for years and last week a federal appeals court affirmed a lower court’s ruling in Edwards’ favor allowing that Medtronic had, in fact, willfully infringed on a single Edwards’ patent. It asked Medtronic to pay damages, […]
Analyst: Edwards Lifesciences’ missed TAVI sales akin to U.S Ryder Cup loss
Losing the Ryder Cup this year to the Europeans was every bit unexpected. Almost as unexpected as Edwards Lifesciences suddenly pre-announcing late Monday that it would miss its 3rd quarter revenue forecasts largely because of poor sales growth for U.S. transcatheter aortic valve replacement procedures. Third quarter U.S. TAVI sales of $55 million were off […]
Are transcatheter aortic valve implantations overused? Edwards Lifesciences disagrees
Many believe that transcatheter aortic valve implantation is one of the most exciting and lucrative new technologies to hit the market providing an option for patients to sick to undergo open heart surgery. Edwards Lifesciences, the Irvine, California, firm has the lead in the U.S. market with its Sapien transcatheter aortic valve replacement system. Medtronic, […]